A randomized, double blind, placebo controlled, parallel group study to determine the effect of Elocalcitol on sperm parameters in infertile male patients.

Trial Profile

A randomized, double blind, placebo controlled, parallel group study to determine the effect of Elocalcitol on sperm parameters in infertile male patients.

Completed
Phase of Trial: Phase II

Latest Information Update: 21 May 2014

At a glance

  • Drugs Elocalcitol (Primary)
  • Indications Male infertility
  • Focus Therapeutic Use
  • Sponsors BioXell Inc
  • Most Recent Events

    • 10 Mar 2009 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
    • 23 Nov 2007 New trial record.
    • 19 Nov 2007 Results are expected at the end of 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top